Royce & Associates’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.7M Buy
667,641
+72,000
+12% +$1.62M 0.14% 246
2025
Q4
$14.1M Sell
595,641
-11,550
-2% -$281K 0.14% 216
2025
Q3
$15.1M Buy
607,191
+214,166
+54% +$4.61M 0.15% 209
2025
Q2
$9.04M Buy
393,025
+89,350
+29% +$2.07M 0.09% 315
2025
Q1
$6.82M Buy
+303,675
New +$7.06M 0.07% 385
2024
Q3
Sell
-292,400
Closed -$5.08M 895
2024
Q2
$5.08M Hold
292,400
0.05% 478
2024
Q1
$5.73M Sell
292,400
-64,000
-18% -$1.35M 0.05% 464
2023
Q4
$8.21M Sell
356,400
-78,000
-18% -$1.75M 0.08% 369
2023
Q3
$9.99M Buy
434,400
+33,000
+8% +$839K 0.1% 283
2023
Q2
$10.5M Buy
401,400
+304,400
+314% +$8.04M 0.1% 300
2023
Q1
$2.68M Buy
97,000
+20,000
+26% +$528K 0.03% 618
2022
Q4
$1.75M Buy
+77,000
New +$2.14M 0.02% 668

Other funds holding PRVA